Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Dermatology | Immunology | Musculoskeletal | Rheumatology

Cutaneous Lupus Erythematosus Clinical Trials

A listing of Cutaneous Lupus Erythematosus medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.

First 1 2 Last

Alabama

Pfizer Investigational Site
Anniston Alabama 36207

A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus

Pfizer Investigational Site
Oxford Alabama 36203

A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus

California

The Institute for Clinical and Translational Science (ICTS)
Irvine California 92697

A clinical trial to evaluate treatments using IVIg for patients with Cutaneous Lupus Erythematosus

Unversity of California, Irvine Healthcare, Dermatology, Gottschalk Medical Plaza
Irvine California 92697

A clinical trial to evaluate treatments using IVIg for patients with Cutaneous Lupus Erythematosus

Pfizer Investigational Site
Los Angeles California 90045

A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus

Research Site
Stanford California 94305

A Phase 1 clinical study for patients with Cutaneous Lupus, Discoid Lupus, Lupus or Systemic Lupus Erythematosus

Florida

Pfizer Investigational Site
Fort Lauderdale Florida 33334

A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus

Pfizer Investigational Site
Orange Park Florida 32073

A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus

Georgia

Research Site
Atlanta Georgia 30322

A Phase 1 clinical study for patients with Cutaneous Lupus, Discoid Lupus, Lupus or Systemic Lupus Erythematosus

Illinois

Pfizer Investigational Site
Chicago Illinois 60611

A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus

Indiana

Pfizer Investigational Site
Indianapolis Indiana 46256

A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus

Indianapolis Indiana

Patients are needed to participate in a clinical research study for Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Systemic or Lupus Erythematosus, Discoid

Michigan

Research Site
Ann Arbor Michigan 48103

A Phase 1 clinical study for patients with Cutaneous Lupus, Discoid Lupus, Lupus or Systemic Lupus Erythematosus

New York

Pfizer Investigational Site
Bronx New York 10467

A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus

North Carolina

Research Site
Durham North Carolina 27710

A Phase 1 clinical study for patients with Cutaneous Lupus, Discoid Lupus, Lupus or Systemic Lupus Erythematosus

Pennsylvania

Pfizer Investigational Site
Duncansville Pennsylvania 16635

A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus

Research Site
Philadelphia Pennsylvania 19104

A Phase 1 clinical study for patients with Cutaneous Lupus, Discoid Lupus, Lupus or Systemic Lupus Erythematosus

Research Site
Philadelphia Pennsylvania 19104

Patients are needed to participate in a clinical research study evaluating AMG 557 and AMG 557 Placebo for the treatment of Cutaneous Lupus or Lupus

Pfizer Investigational Site
Wyomissing Pennsylvania 19610

A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus

Tennessee

Pfizer Investigational Site
Jackson Tennessee 38305

A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus

Texas

Research Site
Dallas Texas 75231

A Phase 1 clinical study for patients with Cutaneous Lupus, Discoid Lupus, Lupus or Systemic Lupus Erythematosus

Research Site
Dallas Texas 75231

Patients are needed to participate in a clinical research study evaluating AMG 557 and AMG 557 Placebo for the treatment of Cutaneous Lupus or Lupus

Dallas Texas 75231

Patients are needed to participate in a clinical research study evaluating AMG 557 and AMG 557 Placebo for the treatment of Cutaneous Lupus or Lupus

Dallas Texas

Patients are needed to participate in a clinical research study for Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Systemic or Lupus Erythematosus, Discoid

Virginia

Pfizer Investigational Site
Norfolk Virginia 23507

A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus

West Virginia

Pfizer Investigational Site
Clarksburg West Virginia 26301

A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus

Australia

Research Site
Carlton Victoria 3053

Patients are needed to participate in a clinical research study evaluating AMG 557 and AMG 557 Placebo for the treatment of Cutaneous Lupus or Lupus

Research Site
Woolloongabba Queensland 4102

Patients are needed to participate in a clinical research study evaluating AMG 557 and AMG 557 Placebo for the treatment of Cutaneous Lupus or Lupus

Canada

Pfizer Investigational Site
Markham Ontario L3P 1A8

A clinical trial to evaluate treatments using PD-0360324 and Placebo for patients with Cutaneous Lupus Erythematosus

Germany

Department of Dermatology, University of Leipzig
Leipzig Saxony 04103

A clinical study for patients with Lupus Erythematosus, Cutaneous or Lupus Erythematosus, Discoid

Klinik und Poliklinik für Hautkrankheiten, Universitätsklinikum Münster
Münster 48149

A clinical trial to evaluate treatments using Daylong products for patients with Cutaneous Lupus Erythematosus